Our business model is structured around SaaS (Software-as-a-Service) with tiered subscription offerings, ensuring accessibility for startups while scaling to enterprise-level clients. A. Subscription Plans 1. Startup/SME Plan: Affordable entry-level plan to support early-stage pharma startups and third-party manufacturers who need guidance but lack large regulatory teams. 2. Consultant/Professional Plan: Targeted at QA/RA professionals and consultants, offering advanced features like risk-based checklists, filing assistance, and automated updates. 3. Enterprise Plan: For large pharmaceutical companies with multiple sites, featuring team collaboration tools, custom integrations, and API access. B. Value-Based Upsells 1. Custom Regulatory Intelligence Reports: Tailored insights for clients preparing critical submissions. 2. Audit Preparation Modules: Helping companies prepare faster with simulation checklists and predictive gap analysis. 3. Premium Support/Training: Hands-on workshops and integration assistance for enterprise clients. C. Future Monetization As VERA grows, we plan to launch a marketplace for regulatory intelligence, where pharma startups and consultants can access specialized modules (e.g., global filings, medical device compliance, biotech regulations). The scalability of this model ensures predictable recurring revenue while allowing us to expand globally. With the regulatory services market projected at $20B+ by 2030, even capturing a small share translates into a massive business opportunity.
Show MoreYear of Establishment2025